On Tuesday, Discover Financial Services (NYSE:DFS)’s shares inclined 0.12% to $58.39.
Discover Financial Services (DFS) is stepping up with another cash rewards innovation. Starting recently, Discover is extending an exclusive offer to new Discover it® cardmembers that doubles all of the cash rewards they’ve earned at the end of their first year for accounts that are open at the time of doubling. There are no limits on how much a cardmember can earn, and they can redeem in any amount, any time, and their rewards never expire.1
In addition to having no annual fee2 on its cards, Discover continues to offer benefits that assist consumers protect themselves from fraud and view their FICO® Credit Score. In April, Discover introduced Freeze ItSM– an on/off switch that cardmembers access on their mobile app and online to prevent new purchases, cash advances and balance transfers in seconds if they misplace their card. Last year, Discover was the first major credit card to give cardmembers their FICO® Credit Scores for free on monthly statements and online.3
Discover Financial Services operates as a direct banking and payment services company in the United States. It operates in two segments, Direct Banking and Payment Services. The Direct Banking segment offers Discover-branded credit cards to individuals; and other consumer products and services, counting private student loans, personal loans, home loans, home equity loans, prepaid cards, and other consumer lending, in addition to deposit products, such as certificates of deposit, money market accounts, savings accounts, checking accounts, and individual retirement arrangement certificates of deposit.
Carnival Corp (NYSE:CCL)’s shares gained 0.53% to $47.03.
Carnival Corp (CCL) declared a quarterly cash dividend of $0.25 (U.S.) per share. The dividend is payable on June 12, 2015, to shareholders of record on May 22, 2015.
Holders of Carnival Corporation common stock or Carnival plc ADSs will receive a dividend payable in U.S. dollars. The dividend for Carnival plc ordinary shares will be payable in sterling unless shareholders elected to receive the dividend in U.S. dollars by May 22, 2015.
Carnival Corporation operates as a cruise company worldwide. It provides vacations to various cruise destinations. The company offers cruise services under the Carnival Cruise Lines, Holland America Line, Princess Cruises, and Seabourn brand names in North America; and AIDA Cruises, Costa Cruises, Cunard, and P&O Cruises names in Europe, Australia, and Asia. It operates 100 cruise ships. It also owns and operates 12 hotels or lodges, and about 300 motor coaches and 20 glass-domed railcars.
At the end of Tuesday’s trade, Biogen Inc (NASDAQ:BIIB)‘s shares dipped -1.46% to $387.62.
Biogen Inc (BIIB) declared that its 2015 Annual Shareholder Meeting will be webcast live on Wednesday, June 10, 2015 at 9:00 a.m. ET. To access the live webcast, please visit Biogen’s Investors section at www.biogen.com. An archived version of the webcast will be accessible following the meeting.
Biogen Inc. discovers, develops, manufactures, and markets therapies for the treatment of neurological, autoimmune, and hematologic disorders in the United States and internationally. It provides AVONEX to treat relapsing multiple sclerosis (MS); TYSABRI to treat relapsing forms of MS and Crohns disease; PLEGRIDY to treat relapsing MS; TECFIDERA to treat MS; FAMPYRA to improve walking in adult patients with MS; ALPROLIX to treat hemophilia B; ELOCTATE to treat hemophilia A; RITUXAN for treating non-Hodgkin’s lymphoma, rheumatoid arthritis, and chronic lymphocytic leukemia (CLL), in addition to two forms of ANCA-associated vasculitis; GAZYVA for the treatment of patients with formerly untreated CLL; and FUMADERM to treat severe plaque psoriasis in adult patients.
Oculus Innovative Sciences, Inc. (NASDAQ:OCLS), ended its Tuesday’s trading session with 8.89% gain, and closed at $0.980.
Oculus Innovative Sciences, Inc. (OCLS) declared that the financial results for its fiscal fourth quarter 2015, ended March 31, 2015, will be released after the U.S. markets close on June 11, 2015. The earnings release will be followed by a conference call at 1:30 p.m. PDT on June 11, 2015, to talk about fiscal fourth quarter and year end results.
Oculus Innovative Sciences, Inc. designs, produces, and markets prescription and non-prescription products based on its Microcyn platform technology for the dermatology, surgical, advanced wound and tissue care, and animal healthcare markets in the United States, Mexico, Europe, and internationally.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
